InterVenn Biosciences IDs Potential Covid-19 Susceptibility Markers
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read More
Search Results for: prostate cancer
Collaborators Launch Unprecedented Effort to Advance Precision Medicine
Unmatched resources will enable researchers to identify distinctive disease mechanisms in small patient subgroups, supporting the development of custom therapeutic approaches.
Read More
January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
Qiagen Expands NGS Portfolio with Oncology and Immunooncology Panels
The research panels can be performed using Qiagen’s GeneReader NGS system and other platforms, providing deep analysis of disease-related genomic mutations.
Read More
Landmark 100,000 Genomes Project Reaches Halfway Milestone
The United Kingdom’s 100,000 Genomes Project, led by Genomics England and Illumina, has reached a major milestone by sequencing 50,000 genomes.
Read More